re: Ann: Trial of Second Neuren Drug Motiva t... this stock is a better play then other biotec stock, as most of our trial is funded by other organisations which means less money burn and so it has less chance of SPP, hence less chance of dilution, and better share holder value
therefore I'm quite happy to hold and will top up when my funding free up
Ann: Trial of Second Neuren Drug Motiva to be Ini, page-5
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.24 |
Change
-0.245(1.58%) |
Mkt cap ! $1.947B | |||
| Open | High | Low | Value | Volume |
| $15.20 | $15.33 | $15.02 | $4.275M | 281.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 387 | $15.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.24 | 735 | 18 |
View Market Depth
| Last trade - 13.56pm 22/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |